Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer. [electronic resource]
Producer: 20030814Description: 2703-7 p. digitalISSN:- 0732-183X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Probability
- Remission Induction
- Risk Assessment
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.